or Try an Advanced Search...

    Technical Analysis for BNR - Burning Rock Biotech Limited

    Grade Last Price % Change Price Change
    D 8.30 3.36% 0.27
    BNR closed up 3.36 percent on Friday, May 17, 2024, on 1.43 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 28
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical BNR trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    New Uptrend Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Support Bullish 3.36%
    50 DMA Support Bullish 3.36%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.36%
    Inside Day Range Contraction 3.36%
    Older End-of-Day Signals for BNR ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot 1 day ago
    Possible NR7 1 day ago
    Possible Inside Day 1 day ago
    10 DMA Support 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BNR Chart by TradingView
    Basic chart:

    Profile

    Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers

    Is BNR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
    Apr 29 Burning Rock Publishes 2023 Annual Report on Form 20-F
    Apr 26 Burning Rock Announces ADS Ratio Change
    Mar 30 Q4 2023 Burning Rock Biotech Ltd Earnings Call
    Mar 29 Burning Rock Biotech GAAP EPS of -$0.22, revenue of $17.1M
    Mar 28 Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
    Feb 2 Here's Why Burning Rock Biotech (NASDAQ:BNR) Must Use Its Cash Wisely
    Jan 8 Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?
    Jan 4 Burning Rock reports receipt of Nasdaq minimum bid price notification
    Jan 4 Burning Rock Announces Receipt of Notification from NASDAQ
    See more BNR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.2
    52 Week Low 5.722
    Average Volume 4,608
    200-Day Moving Average 9.41
    50-Day Moving Average 7.65
    20-Day Moving Average 8.08
    10-Day Moving Average 8.01
    Average True Range 0.74
    RSI (14) 65.99
    ADX 25.11
    +DI 20.36
    -DI 2.81
    Chandelier Exit (Long, 3 ATRs) 6.77
    Chandelier Exit (Short, 3 ATRs) 9.22
    Upper Bollinger Bands 8.74
    Lower Bollinger Band 7.41
    Percent B (%b) 0.67
    BandWidth 16.55
    MACD Line 0.10
    MACD Signal Line 0.08
    MACD Histogram 0.0167
    Fundamentals Value
    Market Cap 852.2 Million
    Num Shares 103 Million
    EPS -0.97
    Price-to-Earnings (P/E) Ratio -8.56
    Price-to-Sales 0.15
    Price-to-Book 0.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.81
    Resistance 3 (R3) 8.77 8.56 8.73
    Resistance 2 (R2) 8.56 8.43 8.58 8.70
    Resistance 1 (R1) 8.43 8.35 8.50 8.47 8.67
    Pivot Point 8.22 8.22 8.25 8.24 8.22
    Support 1 (S1) 8.09 8.09 8.16 8.13 7.93
    Support 2 (S2) 7.88 8.01 7.90 7.90
    Support 3 (S3) 7.75 7.88 7.88
    Support 4 (S4) 7.79